ABT vs PFE: stock comparison and AI forecast
Abbott Laboratories (ABT) and Pfizer Inc (PFE) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ABT Abbott Laboratories
- Market Cap
- $197.53B
- P/E Ratio
- 40.1x
- Size
- large-cap
- AI Forecast
PFE Pfizer Inc
- Price
- $29.88 +12.8% · 6M
- Market Cap
- $170.31B
- P/E Ratio
- 37.8x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ABT is 1.2 times larger than PFE by market capitalization ($197.53B against $170.31B).
- PFE trades at 37.8 times trailing earnings, ABT at 40.1 times.
- ABT turns 9.8% of its revenue into net income, against 6.3% for PFE.
- PFE carries 1.29 times debt per unit of equity, against 1.11 times for ABT.
- PFE yields 5.75% in dividends and ABT 2.19%.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ABT | PFE |
|---|---|---|
| Market Cap | $197.53B | $170.31B |
| P/E Ratio | 40.14x | 37.82x |
| P/B Ratio | 3.87x | 1.91x |
| Dividend Yield | 2.19% | 5.75% |
| EPS | $2.83 | $0.79 |
| Book Value/Share | $29.35 | $15.62 |
| Revenue/Share | $27.74 | $11.16 |
| FCF/Share | $3.89 | $2.07 |
Profitability & Margins
| Metric | ABT | PFE |
|---|---|---|
| ROE | 9.2% | 4.5% |
| ROA | 4.3% | 2.0% |
| ROIC | 7.2% | – |
| Gross Margin | 56.9% | 73.4% |
| Operating Margin | 13.8% | – |
| Net Margin | 9.8% | 6.3% |
| EBT Margin | 13.6% | 6.7% |
| Tax Rate | 28.4% | 4.4% |
Financial Health
| Metric | ABT | PFE |
|---|---|---|
| Current Ratio | 1.45x | 1.42x |
| Quick Ratio | 1.00x | 1.10x |
| D/E Ratio | 1.11x | 1.29x |
| Financial Leverage | 2.12x | 2.30x |
| Interest Coverage | 4.1x | – |
| Working Capital | $7.34B | $13.28B |
Cash Flow
| Metric | ABT | PFE |
|---|---|---|
| Operating Cash Flow | $8.86B | $14.17B |
| Free Cash Flow | $6.76B | $11.79B |
| Capital Spending | -$2.10B | -$2.39B |
| OCF Growth YoY | -2.9% | 8.4% |
| FCF Growth YoY | -2.3% | 13.6% |
| FCF/Sales | 14.0% | 18.5% |
| CapEx/Sales | 4.3% | 3.8% |
Operational Efficiency
| Metric | ABT | PFE |
|---|---|---|
| Asset Turnover | 0.45x | 0.31x |
| Receivables Turnover | 5.3x | 4.5x |
| Inventory Turnover | 2.8x | 1.7x |
| Fixed Assets Turnover | 3.7x | 3.3x |
| Days Sales Outstanding | 68 days | 81 days |
| Days Inventory | 129 days | 216 days |
| Payables Period | – | 88 days |
| Cash Conversion Cycle | – | 210 days |
Income Statement
| Metric | ABT | PFE |
|---|---|---|
| Total Revenue | $48.23B | $63.62B |
| Operating Income | $6.65B | – |
| Net Income | $4.70B | $4.03B |
| R&D Expense | $3.31B | $11.52B |
| SG&A Expense | $15.16B | $13.81B |
| Cost of Goods Sold | $20.77B | $16.94B |
Dividend & Shareholder Information
| Metric | ABT | PFE |
|---|---|---|
| Dividends Per Share | $2.49 | $1.72 |
| Payout Ratio | 88.0% | 217.7% |
| Shares Outstanding | 1739M | 5700M |
| Net Income Growth | -66.4% | -59.0% |
| EPS Growth | -64.2% | -55.1% |
ABT vs PFE: stock comparison and AI forecast
Which is bigger, ABT or PFE?
ABT is 1.2 times larger than PFE by market capitalization ($197.53B against $170.31B).
Which is cheaper on earnings, ABT or PFE?
PFE trades at 37.8 times trailing earnings, ABT at 40.1 times.
Which one does Intratio's AI model rank higher, ABT or PFE?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.